Skip to main content

Table 1 Clinical features and laboratory parameters of the study participants

From: Changes of retinal ganglion cell complex after vitrectomy in rhegmatogenous retinal detachment patients and its correlation with inflammatory blood biomarkers

Variable

 

Patients

25

Age (years)

55.24 ± 10.77

Gender (male/female)

12 / 13 (48.0% / 52.0%)

Diabetes (yes/no)

1 / 24 (4.0% / 96.0%)

Controllable hypertension (yes/no)

8 / 17 (32.0% / 68.0%)

Duration of RRD before surgery (days)

16.80 ± 15.40

Number of quadrants involved

2.13 ± 0.80

Preoperative BCVA (logMAR)

1.30 ± 0.78

Postoperative BCVA (logMAR)

1.00 ± 0.36

Preoperative IOP (mmHg)

15.48 ± 3.24

Postoperative IOP (mmHg)

16.04 ± 3.92

IIOP within a week

9 (36.0%)

Laboratory parameters

 White blood cell (×  109/L)

5.67 ± 1.51

 Neutrophil (×  109/L)

3.46 ± 1.19

 Lymphocyte (×  109/L)

1.69 ± 0.60

 Monocyte (×  109/L)

0.40 ± 0.15

 Platelet (×  109/L)

222.76 ± 54.80

 MPV (fL)

10.73 ± 1.02

 TG (mmol/L)

1.28 ± 0.66

 TCh (mmol/L)

4.60 ± 0.94

 HDL-Ch (mmol/L)

1.39 ± 0.32

 NLR

2.28 ± 1.24

 PLR

141.99 ± 57.42

 LMR

4.69 ± 2.09

 MPR

0.05 ± 0.02

 MHR (× 109/mmol)

0.32 ± 0.17

  1. RRD rhegmatogenous retinal detachment; BCVA best-corrected visual acuity; logMAR logarithm of minimal angle of resolution; IOP intraocular pressure; IIOP increased intraocular pressure; MPV mean platelet volume; TG triglyceride; TCh total cholesterol; HDL-Ch high density lipoprotein cholesterol; NLR neutrophil-to-lymphocyte ratio; PLR platelet-to-lymphocyte ratio; LMR lymphocyte-to-monocyte ratio; MPR MPV-to-platelet ratio; MHR monocyte-to-high-density lipoprotein